                         SEQUENCE LISTING

<110>  BRISTOL-MYERS SQUIBB COMPANY
 
<120>  TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

<130>  12455

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  PRT
<213>  Tobacco vein mottling virus

<400>  1

Met Gly Ser Ser His His His His His His Ser Ser Gly Glu Thr Val 
1               5                   10                  15      


Arg Phe Gln Ser Met 
            20      


<210>  2
<211>  39
<212>  PRT
<213>  Tobacco vein mottling virus

<400>  2

Met Gly Ser Ser His His His His His His Ser Ser Gly Glu Thr Val 
1               5                   10                  15      


Arg Phe Gln Gly Leu Asn Asp Ile Phe Glu Ala Gln Lys Ile Glu Trp 
            20                  25                  30          


His Glu Asp Thr Gly His Met 
        35                  


<210>  3
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Biotinylated histone peptide


<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  ACETYLATION

<400>  3

Ser Gly Arg Gly Lys Gly Gly Lys Gly Leu Gly Lys Gly Gly Ala Lys 
1               5                   10                  15      


Arg His Arg Lys Val 
            20      


